Skip to content Skip to sidebar Skip to footer

Drug discovery

With the help of AI, researchers at MIT have discovered a new category of potential antibiotics.

Using artificial intelligence in the form of deep learning, researchers from MIT have discovered compounds capable of killing methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacteria that reportedly causes over 10,000 deaths in the U.S. each year. This breakthrough was achieved by training a deep learning model using predictive information based on antibiotic potency of a…

Read More

MIT researchers, utilizing AI, have discovered a new category of potential antibiotics.

A powerful new class of antibiotics capable of killing drug-resistant bacteria has been discovered by researchers at the Massachusetts Institute of Technology (MIT), by utilizing a subtype of artificial intelligence (AI) known as deep learning. Results from the study, published in the journal Nature, demonstrate the compound's effectiveness against Methicillin-Resistant Staphylococcus Aureus (MRSA), a bacterium…

Read More

In case an antibiotic is unsuccessful: AI is being utilized by MIT researchers to focus on dormant bacteria.

Since the 1970s, finding new antibiotics has been challenging. The World Health Organization now considers the antimicrobial resistance crisis as one of the top 10 global public health threats. Bacteria can become resistant to antibiotics, especially when an infection is treated repeatedly. Some bacteria become metabolically inert, avoiding detection by antibiotics that only respond to…

Read More

MIT researchers harness artificial intelligence to discover potential new antibiotic classes.

Using deep learning, a form of artificial intelligence, researchers at MIT have discovered a group of compounds that can eliminate methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium that causes over 10,000 deaths in the US annually. The compounds, which display low toxicity against human cells, are considered good potential drug candidates. In a paper published in…

Read More